Harmon Cyrus sold OLMA
January 14, 2026 · Form 4 insider transaction
Harmon Cyrus sold 3,489 shares of Olema Pharmaceuticals, Inc. at $29.12 per share, a transaction worth $101.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,489
Price
$29.12
Total value
$101.6K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 14, 2026
Filing dateJanuary 16, 2026
Shares owned after737,770
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $29.12, and the range of prices were between $29.00 and $29.23. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.